anti-b7-h4 monoclonal antibody nc762
Generic: Anti-B7-H4 Monoclonal Antibody NC762
anti-b7-h4 monoclonal antibody nc762: 1 clinical trial tracked.
anti-b7-h4 monoclonal antibody nc762 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anti-b7-h4 monoclonal antibody nc762, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events as Assessed by CTCAE v5.0
Interventionalopen40 targetStarted 2021-06Completion 2024-018 sites · United StatesNextCure, Inc.